Projects funded by the NCN
Contribution of PHLDA1 to response of neuroblastoma cells to clinical and experimental ways of treatment of high-risk neuroblastoma
2018/29/B/NZ7/01564
Keywords:
PHLDA1 neuroblastoma mice anti GD2 ganglioside-recognizing antibodies
Descriptors:
- NZ7_14: Pharmacy, pharmacotherapy, pharmacology
- NZ1_1: Molecular biology
- NZ3_7: Signal transduction
Panel:
NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution :
Uniwersytet Jagielloński, Wydział Biochemii, Biofizyki i Biotechnologii
woj. małopolskie
Principal investigator (from the host institution):
Number of co-investigators in the project: 6
Call: OPUS 15 - announced on 2018-03-15
Amount awarded: 1 342 400 PLN
Project start date (Y-m-d): 2019-01-28
Project end date (Y-m-d): 2024-01-27
Project duration:: 36 months (the same as in the proposal)
Project status: Project completed
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.